Adaptive Biotechnologies Corporation announced preliminary unaudited revenue results for the first quarter ended March 31, 2024. For the quarter, the company reported Total revenue of approximately $41 to $43 million for the first quarter of 2024, an increase of approximately 12% compared to the first quarter of 2023.